Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Andrew SP Sharp , Gilles Lemesle , Start date: Oct 07, 2025
Pulmonary Embolism (PE) remains a leading cause of cardiovascular morbidity and mortality, requiring timely intervention and coordinated multidisciplinary care. This session will provide an in-depth analysis of the current PE treatment landscape, including the latest clinical trial updates (HI-PEITHO, PEERLESS), institutional decision-making workflows and collaborative patient management… View more
Author(s): Dr Wissam A Jaber Added: 11 months ago
TCT Conference 24 - PEERLESS II shows benefit of large-bore mechanical thrombectomy compared to catheter-directed thrombolysis for intermediate-risk pulmonary embolism (PE) patients.Dr Wissam A Jaber (Emory University Hospital Midtown, US) joins us onsite at TCT Conference to discuss the findings from PEERLESS (NCT06055920; Inari Medical).PEERLESS is a prospective, multicenter, randomized… View more
Author(s): Stefan Stortecky Added: 1 year ago
AHA 23 — We are joined onsite by Prof Stefan Stortecky (Bern University Hospital, Bern, SE) to discuss the findings of the single centre SPECIAL trial that investigated ultrasound-assisted catheter-directed thrombolysis as compared to surgical pulmonary embolectomy for intermediate high or high risk pulmonary embolism.Questions1. What is the reasoning behind this study?2. What is the patient… View more
Author(s): Oliver Schlager Added: 2 months ago
ESC Congress 2025 - New guidelines for catheter-based VTE therapy emphasise the importance of involving vascular experts, and performing procedures in experienced centers.Dr Oliver Schlager (Medical University of Vienna, AT) joins us to discuss the newly released 2025 ESVM Guidelines on Interventional Treatment of Venous Thromboembolism, endorsed by European national societies of Vascular… View more
Author(s): Nicolas M Van Mieghem Added: 3 weeks ago
NVM Cardiology Conference Reflections: What’s Hot at TCT 2025?Join Prof Nicolas Van Mieghem, Transcatheter Interventions Online Course Director, as he shares his critical perspective on some of the key late-breaking data highlights from TCT 2025.What should we expect from the new data? Where should we take a closer look at the existing evidence and the premise of these trials? And which results… View more
Added: 1 week ago
In this episode of Redcliffe Cardiology NVM Reflections, Professor Nicolas Van Mieghem delivers a sharp, practice-focused wrap-up of TCT 2025 from San Francisco. From the SELUTION trials redefining the role of drug-coated balloons, with nearly 80% of patients avoiding a stent, to cost-conscious calcium modification strategies in SHORTCUT and VICTORY, he distills complex data into actionable… View more
Job title: Interventional Cardiologist
Dr José Montero-Cabezas is an interventional cardiologist at Leiden University Medical Center (LUMC), Netherlands. He completed his cardiology training at the 12 de Octubre University Hospital (Complutense University, Madrid), followed by a fellowship in interventional cardiology at LUMC. He holds a PhD from Leiden University, a Master’s degree in Healthcare Management and Administration from CEU… View more
Job title: Professor for Clinical Trials and Medical Director of the Center for Thrombosis and Hemostasis
Prof Stavros Konstantinides, MD, FESC, is Professor for Clinical Trials and Medical Director of the Center for Thrombosis and Hemostasis (CTH) at the University of Mainz, Germany. He is also Professor of Cardiology at the Democritus University of Thrace, Greece. He graduated from the Aristotle University of Thessalonica, Greece, and earned his doctorate degree at the University of Freiburg,… View more
Dr Behnam Tehrani is a System Associate Director for Interventional Cardiology, Executive Director of the Cardiac Catheterization Laboratories for Inova and Co-Director of Complex Coronary Therapeutic Program.Dr Behnam Tehrani also serves as an assistant clinical professor of medicine at both George Washington University and the University of Virginia. He is involved in clinical trials and… View more